Martina Widman

Chief Operating Officer at Diamyd Medical

No bio yet

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Diamyd Medical

Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for the prevention and treatment of autoimmune diabetes. The investigational flagship product Diamyd® is a disease-modifying antigen-specific immunotherapy for the preservation of endogenous insulin production that has Orphan Drug Designation in the U.S. and has been granted Fast Track designation by the U.S. FDA. DIAGNODE-3, a confirmatory Phase III trial is actively recruiting patients with recent-onset Type 1 Diabetes in eight European countries and in the U.S. Diamyd Medical’s shares are traded on Nasdaq First North Growth Market, ticker DMYD B.


Employees

11-50

Links